ClinicalTrials.Veeva

Menu

New Pre-Surgical Scoring System for Uterine Septum

E

Ebtesama Hospital

Status

Enrolling

Conditions

Septate Uterus

Treatments

Diagnostic Test: Shawki Septum Scoring System
Diagnostic Test: ESHRE ASRM Classification

Study type

Interventional

Funder types

Other

Identifiers

NCT05823103
100032023001

Details and patient eligibility

About

Comparing surgical outcomes of Hysteroscopic metroplasty for uterine septum when using the standard ESGE or ASRM classifications vs the novel scoring system dubbed Shawki Septum Scoring System.

Outcomes based primarily on completion of the septal correction (no residual parts) and avoiding complications, the most significant of which are uterine perforation.

Enrollment

100 estimated patients

Sex

Female

Ages

20 to 40 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Uterine Septum diagnosed by 3D ultrasound

Exclusion criteria

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

100 participants in 2 patient groups

Hysteroscopic Metroplasty using ESHRE ASRM Classification
Active Comparator group
Treatment:
Diagnostic Test: ESHRE ASRM Classification
Hysteroscopic Metroplasty using Shawki Septum Scoring System
Active Comparator group
Treatment:
Diagnostic Test: Shawki Septum Scoring System

Trial contacts and locations

1

Loading...

Central trial contact

Yehia Shawki, MRCOG

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems